Cough has been reported as an adverse reaction across 22 drug(s) manufactured by Haleon Us Holdings Llc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 11,824 adverse event reports mention cough in connection with Haleon Us Holdings Llc products.
This page provides a breakdown of which Haleon Us Holdings Llc drugs are most commonly associated with cough, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
Haleon Us Holdings Llc Drugs Reporting Cough
The following Haleon Us Holdings Llc drugs have cough listed in their FDA adverse event reports, sorted by report count:
22 drug(s) manufactured by Haleon Us Holdings Llc have cough listed in their FDA adverse event reports: FLUTICASONE PROPIONATE, CALCIUM CARBONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, IBUPROFEN SODIUM, IBUPROFEN TABLETS, COATED, and others.
How many Cough reports are there for Haleon Us Holdings Llc drugs?
There are a combined 11,824 reports of cough across 22 Haleon Us Holdings Llc drug(s) in the FDA adverse event database.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.